betadex and lauroylcarnitine

betadex has been researched along with lauroylcarnitine* in 1 studies

Other Studies

1 other study(ies) available for betadex and lauroylcarnitine

ArticleYear
Absorption enhancement effect of acylcarnitines through changes in tight junction protein in Caco-2 cell monolayers.
    Drug metabolism and pharmacokinetics, 2011, Volume: 26, Issue:2

    We investigated the effects of lauroylcarnitine and palmitoylcarnitine on major tight junction proteins such as claudins in Caco-2 cell monolayers and also examined the involvement of cholesterol in the effects induced by both acylcarnitines on these proteins. We investigated the effects of lauroylcarnitine and palmitoylcarnitine on the barrier function of tight junctions by measuring transepithelial electrical resistance (TEER) and fluorescein isothiocyanate dextran 40,000 (FD-40) flux. A decrease in the TEER value and an increase in FD-40 flux were observed after incubating Caco-2 cell monolayers with lauroylcarnitine and palmitoylcarnitine for 1 h, suggesting the loss of the barrier function of tight junctions. In addition, lauroylcarnitine and palmitoylcarnitine decreased the protein levels of claudin 1, 4, and 5 but not those of claudin 2, 3, 6, or 7. In addition, palmitoylcarnitine and methyl-β-cyclodextrin increased cholesterol release from the plasma membrane. It is suggested that the effects of palmitoylcarnitine and methyl-β-cyclodextrin on claudin 4 and 5 may be associated with cholesterol leakage from the plasma membrane into the apical side. These results indicate that the protein levels of claudin 4 and 5 are decreased by treatment with palmitoylcarnitine and lauroylcarnitine, and that this change is involved in the absorption-enhancing mechanism.

    Topics: Absorption; beta-Cyclodextrins; Biological Transport; Caco-2 Cells; Carnitine; Cell Membrane; Cholesterol; Claudins; Dextrans; Fluorescein-5-isothiocyanate; Humans; Laurates; Membrane Proteins; Palmitoylcarnitine; Tight Junctions

2011